No Data
World Heart Day: young users account for more than 40% of JD Health's online consultation on cardiovascular disease.
At present, cardiovascular disease has become the number one "killer" threatening people's health. According to the latest data of China Cardiovascular Health and Disease report 2021, the cardiovascular prevalence rate in China is on the rise, with 330 million patients now. Different from the inherent cognition that cardiovascular disease belongs to "senile disease", the younger trend of hypertension, cardiovascular disease and other diseases is becoming more and more obvious. September 29 this year is the 23rd World Heart Day, with the theme of "United as one". It aims to encourage the public to pay more attention to, spread and practice the concept of heart health, so that more people can understand the specific symptoms of cardiovascular disease and have an early onset.
JD Health's "Brand Management Competition" ends. Swisse Swisher creates a "textbook" model for user growth.
Recently, JD Health's first "Brand Management Competition" ended perfectly, and the health brand Swisse Swishi won the "Brand Management Vanguard Award". In this competition, Swisse Swisher brought a "textbook" model of user growth for big health brands. In 2022, compared with the first quarter, the proportion of new customers who issued orders increased by 38% in the second quarter compared with the first quarter, and the number of users transformed from "following" to "placing orders" increased by 37%, providing a new idea for users to refine their operations. All along, JD Health has helped the whole brand with intelligent, refined and creative marketing solutions.
JD Health: interim report 2022
JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 45% Above Its Share Price
Does the September share price for JD Health International Inc. (HKG:6618) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected future cash flows
JD Health International Inc. CEO Enlin Jin on Q2 2022 Results -- Earnings Call Transcript >JDHIF
From Seeking Alpha: JD Health International Inc. CEO Enlin Jin on Q2 2022 Results -- Earnings Call Transcript
JD Health announced mid-term results in 2022: offline DTP pharmacy expanded to 26 provinces across the country to meet users' full-scene drug needs.
On August 23, 2022, JD Health issued the 2022 interim results announcement. During the reporting period, JD Health's total income was 20.2 billion yuan, an increase of 48.3 percent over the same period last year, and the net profit under non-International Financial reporting Standards (Non-IFRS) reached 1.21 billion yuan, an increase of 82.0 percent over the same period last year. As of June 30, 2022, the number of annual active users in the past 12 months exceeded 131 million, compared with a net increase of more than 22.7 million. According to the announcement, JD Health continued to strengthen the omni-channel supply chain system in the first half of the year.
JD Health: interim results announcement for the six months ended June 30, 2022
What Kind Of Shareholders Hold The Majority In JD Health International Inc.'s (HKG:6618) Shares?
A look at the shareholders of JD Health International Inc. (HKG:6618) can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusual to
JD Health: date of board meeting
Investors in JD Health International (HKG:6618) have unfortunately lost 39% over the last year
While it may not be enough for some shareholders, we think it is good to see the JD Health International Inc. (HKG:6618) share price up 22% in a single quarter. But in truth the last year hasn't be
Loading...
